Feb. 06 2012
Source Page: Table showing the incidence of minor and major amputations in practices participating in the 2009-10 National Diabetes Audit for each primary care trust (PCT) in England. 8 p.Found: showing the incidence of minor and major amputations in practices participating in the 2009-10 National Diabetes
Nov. 08 2023
Source Page: MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight lossFound: MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss
Asked by: Matt Western (Labour - Warwick and Leamington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure people with diabetes can continue to access the insulin they need.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
We are aware of supply issues with some insulin products, however the vast majority are in stock. Comprehensive management guidance on alternative products has been issued to the National Health Service where needed.
The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as the other countries around the world, and it can have a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.
There is a team within the Department that deals specifically with medicine supply problems. It has well-established tools and processes to manage medicine supply issues, working closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, and others operating in the supply chain, to help prevent shortages and expedite resupply as soon as possible, to ensure that the risks to patients are minimised.
Correspondence Oct. 18 2023
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)Found: Correspondence from Diabetes UK on consideration of obesity in the prevention inquiry 11.10.23 Correspondence
Automatically make the homeless with diabetes a priority for housing
- Final Signatures: 58
I wish the Government to change legislation to ensure anyone with diabetes is automatically considered a priority for temporary accommodation to start with, and that they are assisted with their housing requirements.
Found: Currently those with diabetes are not automatically considered a priority need for housing.
May. 13 2008
Source Page: Table showing number of emergency hospital admissions where there was a primary diagnosis for diabetic ketoacidosis or hypogylcaemic coma for each year from 2002/03 to 2006/07, broken down by (a) age, (b) sex, (c) type of diabetes and (d) primary care trust. 21 p.Found: hypogylcaemic coma for each year from 2002/03 to 2006/07, broken down by (a) age, (b) sex, (c) type of diabetes
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the diabetes workforce across NHS England in the context of the NICE Technology Appraisal on Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) has published final draft guidance on the use of the hybrid closed loop (HCL) systems for managing blood glucose levels in type 1 diabetes to the National Health Service in England. The draft guidance is out for comment until 28 November 2023. If there are no appeals, then the final guidance will be published in December 2023.
NICE has accepted a funding variation request from NHS England which will see the technology rolled out across England over a five-year period.
The introduction of the HCL systems represents a step-change in care for people living with Type 1 diabetes and NHS England is ensuring that the NHS has the staff, training and patient support in place to safely rollout the technology across the country.
NHS England is engaging with integrated care boards and other stakeholders as part of the development of the HCL implementation strategy. The strategy will provide advice and guidance to integrated care boards and NHS providers on the phased approach to implementation.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase diabetes diagnosis rates in (a) Romford constituency and (b) the London Borough of Havering.
Answered by Will Quince
In 2017/18, a system of identification of those most at-risk of diabetes was launched in the Romford constituency and the London Borough of Havering. Those identified with diabetes are then referred referrals to the National Diabetes Prevention Programme.
Starting in 2022, Primary Care Networks covering both the Romford constituency and the London Borough of Havering have National Diabetes Prevention Programme Champions, whose task is to monitor and improve diagnosis and referrals for diabetes performance.
Latest data as of August 2023 shows local clinicians are on track to exceed last year’s number of referrals to the National Diabetes Prevention Programme.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department for Education:
To ask the Secretary of State for Education, whether she is taking steps to provide support for students with diabetes.
Answered by David Johnston - Parliamentary Under-Secretary (Department for Education)
Pupils at school with medical conditions should be properly supported so that they have full access to education. In 2014, the government introduced a new duty on schools to support pupils with all medical conditions and has published statutory guidance intended to help governing bodies meet their legal responsibilities. This guidance sets out the arrangements they will be expected to make, based on good practice. Schools should ensure they are aware of any pupils with medical conditions and should have policies and processes in place to ensure these can be well managed.
The government encourages all schools to promote healthy eating amongst pupils and provide healthy, tasty and nutritious food and drink. Compliance with the School Food Standards, which restricts foods that are high in fat, salt and sugar, is mandatory. It ensures that pupils always have healthy food and drink options available to them while in school, and that children get the energy and nutrition they need across the school day.
Asked by: George Howarth (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she (a) has made and (b) plans to make an assessment of the potential merits of funding options to ensure the sustainability of T1DE services beyond the pilot phase.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Evaluation by the National Health Service of the initial Type 1 Diabetes with Disordered Eating service (T1DE) pilot sites, in London and Wessex, demonstrated a mean reduction in HbA1c of between 2.3% to 2.5%. Assuming that this level of reduction is maintained, the lifetime quality-adjusted life year gain of these services was estimated at 1.49, which would be cost effective up to a net lifetime cost of £29,800-£44,800.
In response to these initial evaluation findings, NHS England expanded the T1DE programme, supporting provision of new services in an additional five sites from September 2022, expanding coverage to more areas of the country. It is expected that these services will generate further evaluation data to consolidate these early findings, which can be used to inform national and local policy decisions.
NHS England is drawing on learning from existing T1DE services, other emerging evidence and the findings of the recent parliamentary inquiry, to ensure all areas of the country are supported to improve care for those identified as having T1DE. The emergence of these future plans are subject to future spending review settlements for the NHS and level of funding from the NHS England budget allocated to T1DE.
NHS England are also working closely with the first wave of pilot sites including London to ensure that the newer services can benefit from their learning and experience when considering local funding options in advance of March 2025, when the national funding for the five new sites will come to an end.
NHS England is assisting integrated care boards to develop local funding arrangements through the provision of evaluation data, a national programme of support workshops, and an online platform to share learning and good practice.